Company Overview
Snapshot
Founded in October 2018 by Roey Shafrir, Spinol operates with 1–10 employees. The company has completed one funding round. Spinol is currently in the clinical trial phase for its product, Octopus.
Business overview
Spinol is a Health Tech & Life Sciences company focused on developing medical devices for orthopedic applications. The company's core product, Octopus, is a novel implantable annulus closure device designed to seal ruptured spinal discs and prevent reherniation. Spinol targets the healthcare market, specifically providers and hospitals, with its minimally invasive surgical solutions.
Log in to access full profile ›Company Intelligence Q&A
- What is Spinol's primary product?
- Spinol's primary product is Octopus, an implantable annulus closure device designed to seal ruptured spinal discs and eliminate the risk of reherniation.
- When was Spinol founded?
- Spinol was founded in October 2018.
- Who is the founder of Spinol?
- Roey Shafrir is the founder of Spinol.
- In which sector does Spinol primarily operate?
- Spinol primarily operates in the Health Tech & Life Sciences sector, focusing on medical devices.
- What is the current development stage of Spinol's product?
- Spinol's product, Octopus, is currently in the clinical trial stage, as of December 2022. The company is advancing its novel implantable annulus closure device towards commercialization.